How is ADHD diagnosed?
For a diagnosis of ADHD, the patient must meet at least 6 of 9 criteria in the hyperactive and impulsive and/or inattentive symptom domains listed in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5). 1 In addition, symptoms must develop before the patient is 12 years of age, must be present in 2 or more settings, must cause impairment and cannot be better explained by another disorder.
Many conditions mimic or coexist with ADHD, including learning disability, oppositional defiant disorder, depression, anxiety disorders and temperamental variations (Box 1). Distinguishing ADHD from other conditions is challenging and time-consuming. A thorough history that includes information from parents, the child (if appropriate) and an informant from a second setting (e.g., a teacher) regarding ADHD criteria and mimicking and comorbid conditions is necessary. A technical review supports using DSM-based ADHD rating scales to efficiently gather information from multiple settings and aid in making the diagnosis.
2 Some rating scales inquire about symptoms of mimicking and cooccurring conditions and can help identify them. 3 The number of visits needed to diagnose ADHD depends on the complexity of the case, the health care provider's familiarity with the patient and office system support (e.g., support staff, information management system). In our experience, a diagnosis can be made in 2 visits for uncomplicated cases with sufficient information.
How can the goals of therapy be set for the child? Once ADHD is diagnosed, the health care provider and family should work together to develop treatment goals. 3 Goals should be informed by the child's needs and the family's priorities (e.g., increased time spent on assignments without distraction, de creased movement in chair during class, fewer behavioural outbursts). The parent and health care provider should establish metrics to monitor progress to ward these goals (e.g., tracking the number of out bursts at school per day using a daily re port card). 
What interventions should be considered?
Behavioural interventions and medication can be considered alone or in combination based on the family's preferences and goals. According to a comprehensive meta-analysis, some behavioural interventions (Box 2) improve ADHD symptoms. 4 These interventions include parent training, behavioural classroom management and social skills support. Stimulant medications (e.g., methylphenidate, amphetamines) have been extensively studied, and well-designed randomized controlled trials 5 support their safety and efficacy. Children whose ADHD was treated with stimulant medication showed greater improvement in symptoms compared with children who only received behavioural therapy in a study that directly compared the 2 treatment options. 5 For domains such as oppositional behaviour and parent-child interactions, combining behavioural therapy and medications was superior to routine care, whereas medication alone was not. Combined therapy also resulted in the use of lower doses of medication compared with pharmacotherapy alone. 6 When choosing a medication, health care providers should consider factors such as length of action, adherence, ability to swallow pills and cost. The response to treatment may vary by patient, with some children preferentially responding to one stimulant over another. ef fects should be reviewed with the family (Box 2). Before starting stimulants, cardiac risk should be assessed (Box 2), 7 and identified risk factors should trigger further assessment. Once a patient starts taking stimulant medication, blood pressure and pulse, and weight and height in children and adolescents, should be monitored at each follow-up visit. 3 Follow-up should occur regularly, with telephone contact between visits. A visit within 4 weeks of starting medication is recommended, and follow-up should continue at this interval until the dose is stable. 3 Medication should be started at the lowest dose and titrated slowly based on response and adverse effects. Adjustments can be made after about 7 days. 3 As mentioned previously, changes in inattention, hyperactivity and impulsivity can be monitored using rating scales, and by parent, child and teacher report. 3 Other goals can be monitored using metrics established at the start of treatment.
3 If desired outcomes are not achieved, the diagnosis, co-occurring conditions and treatment plan should be reassessed. 3 Once adequate progress toward goals has been made, follow-up should occur at least semiannually. • Second-line: nonstimulant medications (e.g., α2-adrenergic agonists and atomoxetine)
• Additional considerations: adverse effects from stimulants; screening for cardiac risk
• Common adverse effects of stimulants include decreased appetite, headache, abdominal pain and insomnia; less common effects include irritability and mood change; rarely, hallucinations can occur; may unmask or exacerbate tics in some children; may result in minimal growth deceleration (1-2 cm)
• Cardiac risk factors on screening include a history of syncope or near syncope; palpitations; poor exercise tolerance; personal or family history of structural heart disease, arrhythmia or sudden death; physical examination should include blood pressure and auscultation for murmur.
• Further assessment is suggested if increased risk is identified. 
Case revisited
This patient met the diagnostic criteria for ADHD supported by parent-and teacher-rating scales. Classroom accommodations were made to improve oppositional behaviours, and treatment with a methylphenidate preparation was started to reduce symptoms. At a 1-month follow-up visit, the patient's parents and teacher were satisfied with his progress, and rating scale scores supported a decrease in symptoms.
Resources
• More information on behavioural interventions is available from Children and Adults with Attention Deficit/Hyperactivity Disorder (www.chadd.org)
• A number of ADHD-specific rating scales are available, including one that is freely available from the National Initiative for Children's Health Quality: Caring for Children with ADHD: A Resource Toolkit for Clinicians, 1st edition (www.nichq.org/); the same rating scale is also included in the 2nd edition of the toolkit, which is available for purchase from the American Academy of Pediatrics bookstore.
• Additional guidance on medication management and titration can be found in the American Academy of Pediatrics guidelines and supplement. 
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